NeurAxis, Inc.

NRXS
$6.81 (- $0.26 - 3.64%)
Last updated: 2026-06-10 19:55 UTC
NRXS Metrics
Exchange
🇺🇸 NYSE XASE
NYSE Mkt LLCUnited StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS64134X2018
CUSIP64134X201
Market Price6.81
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-1.09
Market Cap$40.7M
Book Value0.23
Price to Book16.537
Beta3.13
52w High6.2
52w Low1.33
Next Earnings DateN/A

NeurAxis, Inc. trades under ticker NRXS on NYSE as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US64134X2018, CUSIP 64134X201. Also searched as NeurAxis.

Related researchNRXS stock priceNRXS share priceNeurAxis stockNeurAxis share price64134X201
About the Company
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. The company offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8-21 years of age with functional abdominal pain associated with irritable bowel syndrome. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.
Price History